Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion type Assertion NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_head.
- NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion description "[Here, we use a genetically engineered mouse model of BRCA2-associated hereditary breast cancer to study drug resistance to several types of chemotherapy and PARP inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_provenance.
- NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion evidence source_evidence_literature NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_provenance.
- NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion SIO_000772 25511378 NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_provenance.
- NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion wasDerivedFrom befree-2016 NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_provenance.
- NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_assertion wasGeneratedBy ECO_0000203 NP1248328.RA6cyJZVS9eG9iNZmPgOXvaHCxj4QYyuzOVYvb-Z68YNs130_provenance.